ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Instrumentation

Agilent to acquire cell analysis expert ACEA Biosciences

by Marc Reisch
October 7, 2018 | APPEARED IN VOLUME 96, ISSUE 40

 

Agilent Technologies has signed a deal to buy ACEA Biosciences for $250 million. The privately held cell analysis instrument maker, founded in 2002, will expand Agilent’s portfolio of tools for life sciences research and clinical diagnostics. Agilent calls cell analysis a strategic growth area that it entered in 2015 with the $235 million acquisition of Seahorse Bioscience. Earlier this year, the firm bought Ireland-based Luxcel Biosciences, a maker of biosensors and assays for analyzing cell metabolism.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment